Artiva Biotherapeutics announces annual shareholder meeting
ARTV•Annual meeting set for Sept. 8, 2026
Artiva Biotherapeutics will hold its annual stockholders meeting virtually on Sept. 8, 2026.
Shareholders will vote to elect two Class II directors, including Brian Daniels and Laura Stoppel. The meeting will also vote on ratifying KPMG as independent auditor for the year ending Dec. 31, 2026.
Proposal to amend equity incentive plan
A separate proposal seeks approval to amend the 2024 Equity Incentive Plan, adding 5,097,095 shares to the share reserve.
The amendment would also include shares underlying pre-funded warrants in the plan’s annual share reserve increase calculation.
